Thomas Arzberger
- Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
2006/08/11 by Heiko Braak, Irina Alafuzoff, Thomas Arzberger +2 · 69 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Alzheimer's disease research and treatments #S100 Proteins and Annexins #Gene expression and cancer classification
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
2017/05/03 by Günter U. Höglinger, Gesine Respondek, Maria Stamelou +50 · 21 citations
Medicine · Neuroscience · #Parkinson's Disease Mechanisms and Treatments #Neurological disorders and treatments #Genetic Neurodegenerative Diseases
- Distribution patterns of tau pathology in progressive supranuclear palsy
2020/05/07 by Gábor G. Kovács, Gabor G. Kovacs, Milica Jecmenica Lukic +27 · 36 citations
Medicine · #Parkinson's Disease Mechanisms and Treatments #Alzheimer's disease research and treatments #Neurological disorders and treatments
- Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
2015/12/10 by Gábor G. Kovács, Gabor G. Kovacs, Isidro Ferrer +86 · 36 citations
Medicine · #Alzheimer's disease research and treatments #Parkinson's Disease Mechanisms and Treatments #Neurological disorders and treatments
- Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis
2014/03/11 by Julia K. Götzl, Julia K Götzl, Kohji Mori +19 · 28 citations
Medicine · #Amyotrophic Lateral Sclerosis Research #Parkinson's Disease Mechanisms and Treatments #Neurogenetic and Muscular Disorders Research
- Assessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium
2008/02/01 by Irina Alafuzoff, Laura Parkkinen, Safa Al‐Sarraj +34 · 24 citations
Medicine · #Parkinson's Disease Mechanisms and Treatments #Neurological disorders and treatments #Botulinum Toxin and Related Neurological Disorders